Chitosan: Its applications in drug-eluting devices

Advances in Polymer Science

Volumn 243, Issue 1, 2011, Pages 185-230

  Chen, Mei Chin ^a   Mi, Fwu Long ^b   Liao, Zi Xian ^c   Sung, Hsing Wen ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b VANUNG UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Biodegradable materials; Controlled release; Crosslinking agent; Drug eluting stent; Tissue regeneration

Indexed keywords

EID: 80052297372     PISSN: 00653195     EISSN: None     Source Type: Book Series    
DOI: 10.1007/12_2011_116     Document Type: Article

References (236)

1. Synowiecki J, Al-Khateeb NA (2003) Production, properties, and some new applications of chitin and its derivatives. Crit Rev Food Sci Nutr 43:145-171 (Pubitemid 38552306)
2. Rinaudo M (2006) Chitin and chitosan: properties and applications. Prog Polym Sci 31:603-632 (Pubitemid 44287019)
3. Shi C, Zhu Y, Ran X et al (2006) Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 133:185-192
4. Madihally SV, Matthew HW (1999) Porous chitosan scaffolds for tissue engineering. Biomaterials 20:1133-1142 (Pubitemid 29233382)
5. Hsieh CY, Tsai SP, Wang DM et al (2005) Preparation of gamma-PGA/chitosan composite tissue engineering matrices. Biomaterials 26:5617-5623
6. Li Z, Ramay HR, Hauch KD et al (2005) Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 26:3919-3928 (Pubitemid 40038783)
7. Ueno H, Mori T, Fujinaga T (2001) Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev 52:105-115 (Pubitemid 33079166)
8. Mi FL, Shyu SS, Wu YB et al (2001) Fabrication and characterization of a sponge-like asymmetric chitosan membrane as a wound dressing. Biomaterials 22:165-173
9. Ishihara M, Nakanishi K, Ono K et al (2002) Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials 23:833-840 (Pubitemid 33108958)
10. Amidi M, Mastrobattista E, Jiskoot W et al (2010) Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 62:59-82
11. Bhattarai N, Gunn J, Zhang M (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 62:83-99
12. Ta HT, Dass CR, Dunstan DE (2008) Injectable chitosan hydrogels for localised cancer therapy. J Control Release 126:205-216
13. Park JH, Saravanakumar G, Kim K et al (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev 62:28-41
14. Kean T, Roth S, Thanou M (2005) Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency. J Control Release 103:643-653 (Pubitemid 40471022)
15. Kim TH, Jiang HL, Jere D et al (2007) Chemical modification of chitosan as a gene carrier in vitro and in vivo. Prog Polym Sci 32:726-753 (Pubitemid 46977435)
16. Liu X, Howard KA, Dong M et al (2007) The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28:1280-1288 (Pubitemid 44816373)
17. Peng SF, Yang MJ, Su CJ et al (2009) Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency. Biomaterials 30:1797-1808
18. Mourya VK, Inamdar NN (2008) Chitosan-modifications and applications: opportunities galore. React Funct Polym 68:1013-1051
19. Kurita K (2001) Controlled functionalization of the polysaccharide chitin. Prog Polym Sci 26:1921-1971 (Pubitemid 33089088)
20. Tharanathan RN, Kittur FS (2003) Chitin-the undisputed biomolecule of great potential. Crit Rev Food Sci Nutr 43:61-87 (Pubitemid 38552311)
21. Sashiwa H, Aiba SI (2004) Chemically modified chitin and chitosan as biomaterials. Prog Polym Sci 29:887-908
22. Muzzarelli RAA (1977) Chitin. Pergamon Press, Oxford, 140
23. Ning M, Wang Q, Sun SL et al (2004) Progress in chemical modification of chitin and chitosan. Prog Chem 16:643-653
24. Kumar MN, Muzzarelli RA,Muzzarelli C et al (2004) Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104:6017-6084 (Pubitemid 40025733)
25. Muzzarelli RAA (1985) Chitin. In: Kroschwitz JI (eds) Encyclopedia of Polymer Science and Technology, vol 3. Wiley, New York, p 430
26. Van der Lubben IM, Verhoef JC, Borchard G et al (2001) Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 14:201-207 (Pubitemid 32884316)
27. Jiang GB, Quan DP, Liao KR et al (2006) Preparation of polymeric micelles based on chitosan bearing a small amount of highly hydrophobic groups. Carbohyd Polym 66:514-520
28. Jiang GB, Quan D, Liao K et al (2006) Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery. Mol Pharm 3:152-160 (Pubitemid 43672251)
29. Hu Y, Du YM, Yang JH et al (2007) Self-aggregation and antibacterial activity of N-acylated chitosan. Polymer 48:3098-3106 (Pubitemid 46709990)
30. Felix L, Hernandez J, Arguelles-Monal WM et al (2005) Kinetics of gelation and thermal sensitivity of N-isobutyryl chitosan hydrogels. Biomacromolecules 6:2408-2415 (Pubitemid 41388250)
31. Zhang J, Chen XG, Li YY et al (2007) Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomed Nanotechnol 3:258-265 (Pubitemid 350192330)
32. Tong YJ, Wang SF, Xu JW et al (2005) Synthesis of O, O'-dipalmitoyl chitosan and its amphiphilic properties and capability of cholesterol absorption. Carbohyd Polym 60:229-233
33. Freier T, Koh HS, Kazazian K et al (2005) Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials 26:5872-5878 (Pubitemid 40798278)
34. Mi FL, Peng CK, Huang MF et al (2005) Preparation and characterization of N-acetylchitosan, N-propionylchitosan and N-butyrylchitosan microspheres for controlled release of 6-mercaptourine. Carbohyd Polym 60:219-227
35. Sashiwa H, Kawasaki N, Nakayama A et al (2002) Chemical modification of chitosan 13 (1) Synthesis of organosoluble, palladium adsorbable, and biodegradable chitosan derivatives toward the chemical plating on plastics. Biomacromolecules 3:1120-1125
36. Wu YS, Hisada K, Maeda S et al (2007) Fabrication and structural characterization of the Langmuir-Blodgett films from a new chitosan derivative containing cinnamate chromophores. Carbohyd Polym 68:766-772 (Pubitemid 46412473)
37. Xu C, Pan H, Jiang H et al (2008) Biocompatibility evaluation of N, O-hexanoyl chitosan as a biodegradable hydrophobic polycation for controlled drug release. J Mater Sci Mater Med 19:2525-2532
38. Chiu YL, Chen SC, Su CJ et al (2009) pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: in vitro characteristics and in vivo biocompatibility. Biomaterials 30:4877-4888
39. Chiu YL, Chen MC, Chen CY et al (2009) Rapidly in situ forming hydrophobically-modified chitosan hydrogels via pH-responsive nanostructure transformation. Soft Matter 5:962-965
40. Chiu YL, Ho YC, Chen YM et al (2010) The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan. J Control Release 146:152-159
41. Domard A, Rinaudo M, Terrassin C (1986) New method for the quaternization of chitosan. Int J Biol Macromol 8:105-107 (Pubitemid 16140315)
42. Thanou M, Verhoef JC, Marbach P et al (2000) Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. J Pharm Sci 89:951-957
43. Di Colo G, Burgalassi S, Zambito Y et al (2004) Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation. J Pharm Sci 93:2851-2862 (Pubitemid 39506634)
44. Hamman JH, Stander M, Kotze AF (2002) Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int J Pharm 232:235-242 (Pubitemid 34076769)
45. Boonyo W, Junginger HE, Waranuch N et al (2007) Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration. J Control Release 121:168-175 (Pubitemid 47212538)
46. Amidi M, Romeijn SG, Borchard G et al (2006) Preparation and characterization of proteinloaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 111:107-116 (Pubitemid 43290000)
47. Mi FL, Wu YY, Lin YH et al (2008) Oral delivery of peptide drugs using nanoparticles selfassembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation. Bioconjug Chem 19:1248-1255
48. Zheng Y, Cai Z, Song XR et al (2009) Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies. J Drug Target 17:294-303
49. Xu Y, Du Y, Huang R et al (2003) Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 24:5015-5022 (Pubitemid 37237631)
50. Hall LD, Yalpani MD (1980) Formation of branched-chain, soluble polysaccharides from chitosan. J Chem Soc Chem Commun 38:1153-1154
51. Morimoto M, Saimoto H, Usui H et al (2001) Biological activities of carbohydrate-branched chitosan derivatives. Biomacromolecules 2:1133-1136 (Pubitemid 34026889)
52. Wu CH, Wu GY (1998) Receptor-mediated delivery of foreign genes to hepatocytes. Adv Drug Deliv Rev 29:243-248 (Pubitemid 28090044)
53. Ashwell G, Harford J (1982) Carbohydrate-specific receptors of the liver. Annu Rev Biochem 51:531-554
54. Kato Y, Onishi H, Machida Y (2001) Biological characteristics of lactosaminated N-succinylchitosan as a liver-specific drug carrier in mice. J Control Release 70:295-307 (Pubitemid 32155453)
55. Park IK, Yang J, Jeong HJ et al (2003) Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment. Biomaterials 24:2331-2337 (Pubitemid 36434053)
56. Murata J, Ohya Y, Ouchi T (1997) Design of quaternary chitosan conjugate having antennary galactose residues as a gene delivery tool. Carbohyd Polym 32:105-109 (Pubitemid 127403350)
57. Mi FL, Wu YY, Chiu YL et al (2007) Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells. Biomacromolecules 8:892-898
58. Kim TH, Park IK, Nah JW et al (2004) Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials 25:3783-3792 (Pubitemid 38327067)
59. Park IK, Ihm JE, Park YH et al (2003) Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier Preparation and physicochemical characterization of GC-graft-PVP/DNA complex (1). J Control Release 86:349-359 (Pubitemid 36084278)
60. Jayakumar R, Prabaharan M, Nair SV et al (2010) Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications. Prog Mater Sci 55:675-709
61. Kim CH, Choi KS (1998) Synthesis and properties of carboxyalkyl chitosan derivatives. J Ind Eng Chem 4:19-25
62. Muzzarelli RAA, Tanfani F, EmanuelliMet al (1982) N-(carboxymethylidene) chitosans and N-(carboxymethyl)-chitosans-novel chelating polyampholytes obtained from chitosan glyoxylate. Carbohydr Res 107:199-214
63. Muzzarelli RAA (1988) Carboxymethylated chitins and chitosans. Carbohyd Polym 8:1-21
64. Pavlov GM, Korneeva EV, Harding SE et al (1998) Dilute solution properties of carboxymethylchitins in high ionic-strength solvent. Polymer 39:6951-6961 (Pubitemid 29007096)
65. Hayes ER (1986) N,O-carboxymethyl chitosan and preparative methods therefor. US Patent 4,619,995
66. Chen LY, Tian ZG, Du YM (2004) Synthesis and pH sensitivity of carboxymethyl chitosanbased polyampholyte hydrogels for protein carrier matrices. Biomaterials 25:3725-3732
67. Lin YH, Liang HF, Chung CK et al (2005) Physically crosslinked alginate/N, O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 26:2105-2113
68. Chen SC, Wu YC, Mi FL et al (2004) A novel pH-sensitive hydrogel composed of N, O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release 96:285-300
69. Yin LC, Fei LK, Cui FY et al (2007) Superporous hydrogels containing poly(acrylic acidco-acrylamide)/O-carboxymethyl chitosan interpenetrating polymer networks. Biomaterials 28:1258-1266
70. Kato Y, Onishi H, Machida Y (2002) Depolymerization of N-succinyl-chitosan by hydrochloric acid. Carbohydr Res 337:561-562
71. Zhu AP, Chen T, Yuan LH et al (2006) Synthesis and characterization of N-succinylchitosan and its self-assembly of nanospheres. Carbohyd Polym 66:274-279
72. Kato Y, Onishi H, Machida Y (2000) Evaluation of N-succinyl-chitosan as a systemic longcirculating polymer. Biomaterials 21:1579-1585 (Pubitemid 30320930)
73. Kato Y, Onishi H, Machida Y (2004) N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates. Biomaterials 25:907-915 (Pubitemid 37371998)
74. Jayakumar R, Nwe N, Tokura S et al (2007) Sulfated chitin and chitosan as novel biomaterials. Int J Biol Macromol 40:175-181 (Pubitemid 46215727)
75. Vikhoreva G, Bannikova G, Stolbushkina P et al (2005) Preparation and anticoagulant activity of a low-molecular-weight sulfated chitosan. Carbohydr Polym 62:327-332 (Pubitemid 41745213)
76. Je JY, Park PJ, Kim SK (2005) Prolyl endopeptidase inhibitory activity of chitosan sulfates with different degree of deacetylation. Carbohydr Polym 60:553-556
77. Can Z, Ping QN, Zhang HJ et al (2003) Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol. Carbohyd Polym 54:137-141
78. Xing RE, Liu S, Yu HH et al (2005) Preparation of high-molecular weight and high-sulfate content chitosans and their potential antioxidant activity in vitro. Carbohyd Polym 61:148-154 (Pubitemid 41013915)
79. Horton D, Just EK (1973) Preparation from chitin of (1-4)-2-amino-2- deoxy-beta-D-glucopyranuronan and its 2-sulfoamino analog having blood anticoagulant properties. Carbohydr Res 29:173-179
80. Whistler RL, Kosik M (1971) Anticoagulant activity of oxidized and N-sulfated and O-sulfated chitosan. Arch Biochem Biophys 142:106-110
81. Muzzarelli RAA, Tanfani F, Emanuelli M et al (1986) In: Muzzarelli R, Jeuniaux C, Goodday WG (eds) Chitin in nature and technology. Plenum, New York, p 469
82. Zhou HJ, Qian JC, Wang J et al (2009) Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. Biomaterials 30:1715-1724
83. Ho YC, Wu SJ, Mi FL et al (2010) Thiol-modified chitosan sulfate nanoparticles for protection and release of basic fibroblast growth factor. Bioconjug Chem 21:28-38
84. Kast CE, Bernkop-Schnurch A (2001) Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22:2345-2352 (Pubitemid 32666227)
85. Kast CE, Bernkop-Schnurch A (2002) Polymer-cysteamine conjugates: new mucoadhesive excipients for drug delivery? Int J Pharm 234:91-99 (Pubitemid 34142614)
86. Bernkop-Schnurch A, Hornof M, Zoidl T (2003) Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm 260:229-237 (Pubitemid 36773920)
87. Kafedjiiski K, Krauland AH, Hoffer MH et al (2005) Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials 26:819-826 (Pubitemid 39179966)
88. Sakloetsakun D, Hombach JM, Bernkop-Schnurch A (2009) In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents. Biomaterials 30:6151-6157
89. Hassan EE, Gallo JM (1990) A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharmaceut Res 7:491-495 (Pubitemid 20322199)
90. Leitner VM, Walker GF, Bernkop-Schnurch A (2003) Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm 56:207-214 (Pubitemid 37072104)
91. Foger F, Schmitz T, Bernkop-Schnurch A (2006) In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials 27:4250-4255
92. Werle M, Hoffer M (2006) Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111:41-46 (Pubitemid 43289993)
93. Bernkop-Schnurch A, Kast CE, Guggi D (2003) Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J Control Release 93:95-103 (Pubitemid 37421352)
94. Shu XZ, Zhu KJ (2002) Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int J Pharm 233:217-225 (Pubitemid 34230434)
95. Dambies L, Vincent T, Domard A et al (2001) Preparation of chitosan gel beads by ionotropic molybdate gelation. Biomacromolecules 2:1198-1205 (Pubitemid 34026898)
96. Brack HP, Tirmizi SA, RisenWM(1997) A spectroscopic and viscometric study of the metal ion-induced gelation of the biopolymer chitosan. Polymer 38:2351-2362 (Pubitemid 127422212)
97. Mi FL, Shyu SS, Lee ST et al (1999) Kinetic study of chitosan- tripolyphosphate complex reaction and acid-resistive properties of the chitosan-tripolyphosphate gel beads prepared by in-liquid curing method. J Polym Sci Pol Phys 37:1551-1564
98. Mi FL, Shyu SS, Wong TB et al (1999) Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. II. Effect of pH-dependent ionic crosslinking or interpolymer complex using tripolyphosphate or polyphosphate as reagent. J Appl Polym Sci 74:1093-1107
99. Aydin Z, Akbuga J (1996) Chitosan beads for the delivery of salmon calcitonin: preparation and release characteristics. Int J Pharm 131:101-103 (Pubitemid 26143833)
100. Shu XZ, Zhu KJ (2000) A novel approach to prepare tripolyphosphate/ chitosan complex beads for controlled release drug delivery. Int J Pharm 201:51-58 (Pubitemid 30364969)
101. Bodmeier R, Oh KH, Pramar Y (1989) Preparation and evaluation of drug-containing chitosan beads. Drug Dev Ind Pharm 15:1475-1494
102. Janes KA, Fresneau MP, Marazuela A et al (2001) Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 73:255-267 (Pubitemid 32539254)
103. Fernandez-Urrusuno R, Calvo P, Remunan-Lopez C et al (1999) Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res 16:1576-1581 (Pubitemid 29510555)
104. Peppas NA, Bures P, LeobandungWet al (2000) Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 50:27-46 (Pubitemid 30326687)
105. Mi FL, Kuan CY, Shyu SS et al (2000) The study of gelation kinetics and chain-relaxation properties of glutaraldehyde-cross-linked chitosan gel and their effects on microspheres preparation and drug release. Carbohyd Polym 41:389-396
106. Gupta KC, Jabrail FH (2006) Effects of degree of deacetylation and cross-linking on physical characteristics, swelling and release behavior of chitosan microspheres. Carbohyd Polym 66:43-54 (Pubitemid 44353703)
107. Arguelles-Monal W, Goycoolea FM, Peniche C et al (1998) Rheological study of the chitosan glutaraldehyde chemical gel system. Polym Gels Netw 6:429-440 (Pubitemid 128451143)
108. Hassan EE, Parish RC, Gallo JM (1992) Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharm Res 9:390-397
109. Jameela SR, Jayakrishnan A (1995) Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials 16:769-775
110. Chung TW, Lin SY, Liu DZ et al (2009) Sustained release of 5-FU from poloxamer gels interpenetrated by crosslinking chitosan network. Int J Pharm 382:39-44
111. Thanoo BC, Sunny MC, Jayakrishnan A (1992) Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J Pharm Pharmacol 44:283-286
112. Jameela SR, Kumary TV, Lal AV et al (1998) Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. J Control Release 52:17-24 (Pubitemid 28123169)
113. Gupta KC, Jabrail FH (2006) Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman. Carbohydr Res 341:744-756
114. Dini E, Alexandridou S, Kiparissides C (2003) Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications. J Microencapsul 20:375-385 (Pubitemid 36621478)
115. Fujikawa S, Yokota T, Koga K et al (1987) The continuous hydrolysis of geniposide to genipin using immobilized beta-glucosidase on calcium alginate gel. Biotechnol Lett 9:697-702
116. Sung HW, Huang RN, Huang LL et al (1999) In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. J Biomater Sci Polym Ed 10:63-78 (Pubitemid 29097232)
117. Mi FL, Tan YC, Liang HC et al (2001) In vitro evaluation of a chitosan membrane crosslinked with genipin. J Biomater Sci Polym Ed 12:835-850
118. Mi FL, Tan YC, Liang HF et al (2002) In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials 23:181-191
119. Mi FL, Sung HW, Shyu SS (2000) Synthesis and characterization of a novel chitosan-based network prepared using naturally occurring crosslinker. J Polym Sci Pol Chem 38:2804-2814
120. Mi FL, Shyu SS, Peng CK (2005) Characterization of ring-opening polymerization of genipin and pH-dependent cross-linking reactions between chitosan and genipin. J Polym Sci Pol Chem 43:1985-2000
121. Mi FL, Sung HW, Shyu SS (2002) Drug release from chitosan-alginate complex beads reinforced by a naturally occurring cross-linking agent. Carbohyd Polym 48:61-72
122. Liu BS, Huang TB, Yao CH et al (2009) Novel wound dressing of non-woven fabric coated with genipin-crosslinked chitosan and bletilla striata herbal extract. J Med Biol Eng 29:60-67
123. Muzzarelli RAA (2009) Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids. Carbohyd Polym 77:1-9
124. Mi FL, Sung HW, Shyu SS et al (2003) Synthesis and characterization of biodegradable TPP/genipin co-crosslinked chitosan gel beads. Polymer 44:6521-6530
125. Wei YC, Hudson SM, Mayer JM et al (1992) The crosslinking of chitosan fibers. J Polym Sci A Polym Chem 30:2187-2193
126. Welsh ER, Price RR (2003) Chitosan cross-linking with a water-soluble, blocked diisocyanate. Solvates and hydrogels. Biomacromolecules 4:1357-1361 (Pubitemid 37184652)
127. Roy SK, Todd JG, Glasser WG (1998) Crosslinked hydrogel beads from chitosan. US Patent 5,770,712
128. Wang SL, Liu WS, Han BQ et al (2009) Study on a hydroxypropyl chitosan-gelatin based scaffold for corneal stroma tissue engineering. Appl Surf Sci 255:8701-8705
129. Subramanian A, Rau AV, Kaligotla H (2006) Surface modification of chitosan for selective surface-protein interaction. Carbohyd Polym 66:321-332 (Pubitemid 44585064)
130. Yu SH, Mi FL, Shyu SS et al (2006) Miscibility, mechanical characteristic and platelet adhesion of 6-O-carboxymethylchitosan/polyurethane semi-IPN membranes. J Membr Sci 276:68-80
131. Chen MC, Chang Y, Liu CT et al (2009) The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents. Biomaterials 30:79-88
132. Mi FL, Shyu SS, Chen CT et al (1999) Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release. Biomaterials 20:1603-1612
133. Mi FL, Shyu SS, Chen CT et al (2002) Adsorption of indomethacin onto chemically modified chitosan beads. Polymer 43:757-765
134. Chenite A, Chaput C, Wang D et al (2000) Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21:2155-2161 (Pubitemid 30612386)
135. Sakai S, Yamada Y, Zenke T et al (2009) Novel chitosan derivative soluble at neutral pH and in-situ gellable via peroxidase-catalyzed enzymatic reaction. J Mater Chem 19:230-235
136. Jin R, Moreira Teixeira LS, Dijkstra PJ et al (2009) Injectable chitosan-based hydrogels for cartilage tissue engineering. Biomaterials 30:2544-2551
137. Babapulle MN, Eisenberg MJ (2002) Coated stents for the prevention of restenosis: Part I. Circulation 106:2734-2740 (Pubitemid 35364930)
138. Betriu A, Masotti M, Serra A et al (1999) Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol 34:1498-1506 (Pubitemid 29528664)
139. Chen MC, Liang HF, Chiu YL et al (2005) A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus. J Control Release 108:178-189
140. Wessely R (2010) New drug-eluting stent concepts. Nat Rev Cardiol 7:194-203
141. Honda Y (2009) Drug-eluting stents. Insights from invasive imaging technologies. Circ J 73:1371-1380
142. Kukreja N, Onuma Y, Daemen J et al (2008) The future of drug-eluting stents. Pharmacol Res 57:171-180
143. Wykrzykowska JJ, Onuma Y, Serruys PW (2009) Advances in stent drug delivery: the future is in bioabsorbable stents. Expert Opin Drug Deliv 6:113-126
144. Luscher TF, Steffel J, Eberli FR et al (2007) Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115:1051-1058 (Pubitemid 46328299)
145. Virmani R, Guagliumi G, Farb A et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701-705 (Pubitemid 38222887)
146. Tsimikas S (2006) Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. J Am Coll Cardiol 47:2112-2115
147. Joner M, Finn AV, Farb A et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193-202 (Pubitemid 43929240)
148. Meng S, Liu Z, Shen L et al (2009) The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials 30:2276-2283
149. Hardhammar PA, van Beusekom HM, Emanuelsson HU et al (1996) Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93:423-430 (Pubitemid 26043600)
150. Thierry B, Winnik FM, Merhi Y et al (2003) Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromolecules 4:1564-1571 (Pubitemid 37455567)
151. Heublein B, Evagorou EG, Rohde R et al (2002) Polymerized degradable hyaluronan-a platform for stent coating with inherent inhibitory effects on neointimal formation in a porcine coronary model. Int J Artif Organs 25:1166-1173 (Pubitemid 36109103)
152. Morra M (2000) On the molecular basis of fouling resistance. J Biomater Sci Polym Ed 11:547-569 (Pubitemid 30623753)
153. Wang PG, Xian M, Tang X et al (2002) Nitric oxide donors: chemical activities and biological applications. Chem Rev 102:1091-1134 (Pubitemid 35377604)
154. Provost P, Merhi Y (1997) Endogenous nitric oxide release modulates mural platelet thrombosis and neutrophil-endothelium interactions under low and high shear conditions. Thromb Res 85:315-326 (Pubitemid 27143807)
155. Shirota T, Yasui H, Shimokawa H et al (2003) Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 24:2295-2302 (Pubitemid 36434048)
156. Aoki J, Serruys PW, van Beusekom H et al (2005) Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 45:1574-1579 (Pubitemid 40704488)
157. Campbell PG, Hall JA, Harcombe AA et al (2000) The Jomed covered stent graft for coronary artery aneurysms and acute perforation: a successful device which needs careful deployment and may not reduce restenosis. J Invasive Cardiol 12:272-276
158. Schachinger V, Hamm CW, Munzel T et al (2003) A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 42:1360-1369 (Pubitemid 37267273)
159. Roukoz B, Arjornand H, Surabhi S et al (2003) Initial US experience with membranecovered stents in the treatment of saphenous vein graft lesions: roll-in phase of the barricade trial. J Am Coll Cardiol 41:82A
160. Thierry B, Merhi Y, Silver J et al (2005) Biodegradable membrane-covered stent from chitosan-based polymers. J Biomed Mater Res A 75:556-566 (Pubitemid 47233439)
161. Yakacki CM, Shandas R, Lanning C et al (2007) Unconstrained recovery characterization of shape-memory polymer networks for cardiovascular applications. Biomaterials 28:2255-2263 (Pubitemid 46282928)
162. Nebeker JR, Virmani R, Bennett CL et al (2006) Hypersensitivity cases associated with drugeluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47:175-181 (Pubitemid 43005183)
163. Azarbal B, Currier JW (2006) Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer? J Am Coll Cardiol 47:182-183 (Pubitemid 43005184)
164. Koster R, Vieluf D, Kiehn M et al (2000) Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 356:1895-1897
165. Chen MC, Tsai HW, Chang Y et al (2007) Rapidly self-expandable polymeric stents with a shape-memory property. Biomacromolecules 8:2774-2780 (Pubitemid 47516929)
166. Chen MC, Tsai HW, Liu CT et al (2009) A nanoscale drug-entrapment strategy for hydrogelbased systems for the delivery of poorly soluble drugs. Biomaterials 30:2102-2111
167. Tamai H, Igaki K, Kyo E et al (2000) Initial and 6-month results of biodegradable polyl-lactic acid coronary stents in humans. Circulation 102:399-404 (Pubitemid 30490677)
168. Venkatraman SS, Tan LP, Joso JF et al (2006) Biodegradable stents with elastic memory. Biomaterials 27:1573-1578 (Pubitemid 41739582)
169. Torchilin VP (2004) Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 61:2549-2559 (Pubitemid 39591627)
170. Ip JH, Fuster V, Israel D et al (1991) The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 17:77B-88B
171. Casscells W (1992) Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 86:723-729
172. Marx SO, Jayaraman T, Go LO et al (1995) Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76:412-417
173. Kuo CK, Ma PX (2001) Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials 22:511-521 (Pubitemid 32015873)
174. Ko CS, Wu CH, Huang HH et al (2007) Genipin cross-linking of type II collagen-chondroitin sulfate-hyaluronan scaffold for articular cartilage therapy. J Med Biol Eng 27:7-14
175. Cauich-Rodriguez JV, Deb S, Smith R (1996) Effect of cross-linking agents on the dynamic mechanical properties of hydrogel blends of poly(acrylic acid)-poly(vinyl alcohol-vinyl acetate). Biomaterials 17:2259-2264 (Pubitemid 26390381)
176. Chen MC, Liu CT, Tsai HW et al (2009) Mechanical properties, drug eluting characteristics and in vivo performance of a genipin-crosslinked chitosan polymeric stent. Biomaterials 30:5560-5571
177. Sung HW, Hsu CS, Lee YS et al (1996) Crosslinking characteristics of an epoxy-fixed porcine tendon: effects of pH, temperature, and fixative concentration. J Biomed Mater Res 31:511-518
178. Sung HW, Liang IL, Chen CN et al (2001) Stability of a biological tissue fixed with a naturally occurring crosslinking agent (genipin). J Biomed Mater Res 55:538-546 (Pubitemid 32336284)
179. Yin M, Yuan Y, Liu C et al (2009) Development of mussel adhesive polypeptide mimics coating for in-situ inducing re-endothelialization of intravascular stent devices. Biomaterials 30:2764-2773
180. Venkatesan J, Kim SK (2010) Chitosan composites for bone tissue engineering-an overview. Mar Drugs 8:2252-2266
181. Hu Q, Li B, WangMet al (2004) Preparation and characterization of biodegradable chitosan/hydroxyapatite nanocomposite rods via in situ hybridization: a potential material as internal fixation of bone fracture. Biomaterials 25:779-785 (Pubitemid 37376416)
182. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738-746 (Pubitemid 29407375)
183. Campos M, Cordi L, Duran N et al (2006) Antibacterial activity of chitosan solution for wound dressing. Macromol Symp 245-246:515-518 (Pubitemid 46396363)
184. Khor E, Lim LY (2003) Implantable applications of chitin and chitosan. Biomaterials 24:2339-2349 (Pubitemid 36434054)
185. Obara K, Ishihara M, Ishizuka T et al (2003) Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials 24:3437-3444 (Pubitemid 36703118)
186. Mizuno K, Yamamura K, Yano K et al (2003) Effect of chitosan film containing basic fibroblast growth factor on wound healing in genetically diabetic mice. J Biomed Mater Res A 64(1):177-181 (Pubitemid 37521481)
187. Liu Y, Cai S, Shu XZ et al (2007) Realease of basic fibroblast growth factor from a crosslinked glycosaminoglycan hydrogel promotes wound healing. Wound Repair Regen 15:245-251 (Pubitemid 46376386)
188. Kawai K, Suzuki S, Tabata Y et al (2000) Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 21:489-499 (Pubitemid 30067585)
189. Judith R, Nithya M, Rose C et al (2010) Application of a PDGF-containing novel gel for cutaneous wound healing. Life Sci 87:1-8
190. Choi JS, Yoo HS (2010) Pluronic/chitosan hydrogels containing epidermal growth factor with wound-adhesive and photo-crosslinkable properties. J Biomed Mater Res A 95A:564-573
191. Sato M, Asazuma T, Ishihara M et al (2003) An atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) for the culture of annulus fibrosus cells from an intervertebral disc. J Biomed Mater Res A 64A:249-256 (Pubitemid 37521444)
192. Pannier AK, Shea LD (2004) Controlled release systems for DNA delivery. Mol Ther 10:19-26 (Pubitemid 38878145)
193. Guo R, Xu S, Ma L et al (2011) The healing of full-thickness burns treated by using plasmid DNA encoding VEGF-165 activated collagen-chitosan dermal equivalents. Biomaterials 32:1019-1031
194. Fujie T, SaitoA,KinoshitaMet al (2010)Dual therapeutic action of antibiotic-loaded nanosheets for the treatment of gastrointestinal tissue defects. Biomaterials 31:6269-6278
195. Ong SY, Wu J, Moochhala SM et al (2008) Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials 29:4323-4332
196. Mi FL, Wu YB, Shyu SS et al (2002) Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 59:438-449
197. Jin R, Teixeira LSM, Dijkstra PJ et al (2009) Injectable chitosan-based hydrogels for cartilage tissue engineering. Biomaterials 30:2544-2551
198. Lahiji A, Sohrabi A, Hungerford DS et al (2000) Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res 51:586-595 (Pubitemid 30450717)
199. Sechriest VF, Miao YJ, Niyibizi C et al (1999) GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis. J Biomed Mater Res 49:534-541 (Pubitemid 30030473)
200. Nettles DL, Elder SH, Gilbert JA (2002) Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng 8:1009-1016 (Pubitemid 35397246)
201. Ragetly G, Griffon DJ, Chung YS (2010) The effect of type II collagen coating of chitosan fibrous scaffolds on mesenchymal stem cell adhesion and chondrogenesis. Acta Biomater 6:3988-3997
202. Ragetly GR, Slavik GJ, Cunningham BT et al (2010) Cartilage tissue engineering on fibrous chitosan scaffolds produced by a replica molding technique. J Biomed Mater Res A 93:46-55
203. Swieszkowski W, Tuan BH, Kurzydlowski KJ et al (2007) Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng 24:489-495 (Pubitemid 350123179)
204. Frenkel SR, Bradica G, Brekke JH et al (2005) Regeneration of articular cartilage-evaluation of osteochondral defect repair in the rabbit using multiphasic implants. Osteoarthritis Cartilage 13:798-807 (Pubitemid 41263938)
205. Malafaya PB, Oliveira JT, Reis RL (2010) The effect of insulin-loaded chitosan particleaggregated scaffolds in chondrogenic differentiation. Tissue Eng A 16:735-747
206. Lee JE, Kim KE, Kwon IC et al (2004) Effects of the controlled-released TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials 25:4163-4173 (Pubitemid 38388580)
207. Kim IY, Seo SJ, Moon HS et al (2008) Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv 26:1-21
208. Ignotz RA, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345 (Pubitemid 17198877)
209. Kim SE, Park JH, Cho YW et al (2003) Porous chitosan scaffold containing microspheres loaded with transforming growth factor-beta1: implications for cartilage tissue engineering. J Control Release 91:365-374 (Pubitemid 36976767)
210. Guo T, Zhao J, Chang J et al (2006) Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation. Biomaterials 27:1095-1103 (Pubitemid 41566703)
211. De la Riva B, Sanchez E, Hernandez A et al (2010) Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release 143:45-52
212. Seol YJ, Lee JY, Park YJ et al (2004) Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett 26:1037-1041
213. Kim IS, Park JW, Kwon IC et al (2002) Role of BMP, betaig-h3, and chitosan in early bony consolidation in distraction osteogenesis in a dog model. Plast Reconstr Surg 109:1966-1977 (Pubitemid 34492426)
214. Park YJ, Lee YM, Lee JY et al (2000) Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J Control Release 67:385-394 (Pubitemid 30303850)
215. Lee JY, Nam SH, Im SY et al (2002) Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release 78:187-197
216. Moore DC, Ehrlich MG, McAllister SC et al (2009) Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. J Bone Joint Surg Am 91:1973-1984
217. Dimitriou R, Tsiridis E, Giannoudis PV (2005) Current concepts of molecular aspects of bone healing. Injury 36:1392-1404 (Pubitemid 41618169)
218. Yilgor P, Tuzlakoglu K, Reis RL et al (2009) Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 30:3551-3559
219. Urist MR (1965) Bone: formation by autoinduction. Science 150:893-899
220. Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2:1-13
221. White AP, Vaccaro AR, Hall JA et al (2007) Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int Orthop 31:735-741 (Pubitemid 350160312)
222. McKay WF, Peckham SM, Badura JM (2007) A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 31: 729-734 (Pubitemid 350160311)
223. Zhang Y, Zhang M (2002) Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J Biomed Mater Res 62:378-386 (Pubitemid 35332201)
224. Jia WT, Zhang X, Zhang CQ et al (2010) Elution characteristics of teicoplanin-loaded biodegradable borate glass/chitosan composite. Int J Pharm 387:184-186
225. Bhattarai N, Li ZS, Gunn J et al (2009) Natural-synthetic polyblend nanofibers for biomedical applications. Adv Mater 21:2792-2797
226. Schmidt CE, Leach JB (2003) Neural tissue engineering: strategies for repair and regeneration. Annu Rev Biomed Eng 5:293-347 (Pubitemid 40125315)
227. Pfister LA, Alther E, Papaloizos M et al (2008) Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits. Eur J Pharm Biopharm 69:563-572
228. Ao Q, Fung CK, Tsui AY et al (2011) The regeneration of transected sciatic nerves of adult rats using chitosan nerve conduits seeded with bone marrow stromal cell-derived Schwann cells. Biomaterials 32:787-796
229. Ding F, Wu J, Yang Y et al (2010) Use of tissue-engineered nerve grafts consisting of a chitosan/poly(lactic-co-glycolic acid)-based scaffold included with bone marrow mesenchymal cells for bridging 50-mm dog sciatic nerve gaps. Tissue Eng A 16:3779-3790
230. Jiao H, Yao J, Yang Y et al (2009) Chitosan/polyglycolic acid nerve grafts for axon regeneration from prolonged axotomized neurons to chronically denervated segments. Biomaterials 30:5004-5018
231. Wang X, Hu W, Cao Y et al (2005) Dog sciatic nerve regeneration across a 30-mm defect bridged by a chitosan/PGA artificial nerve graft. Brain 128:1897-1910 (Pubitemid 41373662)
232. Boyd JG, Gordon T (2003) Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 27:277-324
233. Hoke A, Redett R, Hameed H et al (2006) Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci 26:9646-9655 (Pubitemid 44427703)
234. Deumens R, Bozkurt A, Meek MF et al (2010) Repairing injured peripheral nerves: bridging the gap. Prog Neurobiol 92:245-276
235. Patel M, Mao L, Wu B et al (2009) GDNF blended chitosan nerve guides: an in vivo study. J Biomed Mater Res A 90:154-165
236. Patel M, Mao L, Wu B et al (2007) GDNF-chitosan blended nerve guides: a functional study. J Tissue Eng Regen Med 1:360-367